UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 1 - 50 of 1917

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Are nomograms needed in the management of bladder cancer? - Abstract
Tuesday, 09 February 2010
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
read more

BJUI Mini Reviews - The effect of age and gender on bladder cancer: A critical review of the literature
Monday, 08 February 2010
This review examines previous reports on the influence of age and gender on the incidence, biology, mortality and treatment of urothelial carcinoma of the bladder (UCB).
Login to read more...

Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: Review of the evidence and recommendations - Abstract
Monday, 08 February 2010
UMC St Radboud, Netherlands, Nijmegen, The Netherlands.
read more

Solitary cystic cerebral metastasis from transitional cell carcinoma of the bladder - Abstract
Monday, 08 February 2010
Department of Neurosurgery, University Hospital of Ioannina, Greece.
read more

Role of biomarkers to predict outcomes and response to therapy - Abstract
Monday, 08 February 2010
Department of Urology, The University of Texas, Southwestern Medical Center, Dallas, TX 75390-9110, USA.
read more

Beyond the Abstract - Pancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: A case report and review of the literature, by Miguel Alvarez-Mugica, MD
Friday, 05 February 2010
BERKELEY, CA (UroToday.com) - Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976,
Login to read more...

Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods - Abstract
Friday, 05 February 2010
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
read more

Robot-assisted pelvic lymphadenectomy for bladder cancer-where have we reached by 2009 - Abstract
Friday, 05 February 2010
Department of Urology, Wake Forest University Medical School and Baptist Medical Center, Medical Centre Boulevard, Winston Salem, North Carolina.
read more

“The Cost Effective Choice” NMP22® BladderChek® test an aid in the early detection of bladder cancer
Thursday, 04 February 2010
ATLANTA, GA, USA (UroToday.com) - Alere Women’s & Children’s Health invites you to attend a webinar presentation:
read more

Beyond the Abstract - Complications and mortality after radical cystectomy for bladder transitional cell cancer, by Rafael Boscolo-Berto, MD
Thursday, 04 February 2010
BERKELEY, CA (UroToday.com) - The relation between the complication rate and patient gender is controversial, and the literature data are quite ambiguous with a few published studies failing to show any clear significant difference.
Login to read more...

UroToday.com and Verathon® partner to launch new online information center to help health care professionals reduce catheter-associated urinary tract infections
Wednesday, 03 February 2010
SAN FRANCISCO, CA, USA (Press Release) - February 3, 2010
read more

Survival after cystectomy for invasive bladder cancer - Abstract
Wednesday, 03 February 2010
Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
read more

Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art - Abstract
Wednesday, 03 February 2010
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
read more

Incidental prostate cancer at radical cystoprostatectomy: Implications for apex-sparing surgery - Abstract
Wednesday, 03 February 2010
Department of Urology, Eberhard-Karls University, Tübingen, Germany.
read more

"FISHing" to detect urinary and other cancers: Validation of an imaging system to aid in interpretation - Abstract
Wednesday, 03 February 2010
Associated Regional and University Pathologists (ARUP) Laboratories Institute for Clinical and Experimental Pathology, ARUP Laboratories, Inc., Salt Lake City, Utah.
read more

Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression - Abstract
Tuesday, 02 February 2010
Departments of Urology, Surgery, Pathology, Internal Medicine, and Population Studies Center, University of Michigan, Ann Arbor, Michigan.
read more

External stoma and peristomal complications following radical cystectomy and ileal conduit diversion: A systematic review - Abstract
Tuesday, 02 February 2010
Department of Surgery (Urology), McGill University Health Center & Montreal General Hospital, Montreal, Quebec, Canada.
read more

Comprehensive surgical and chemotherapy treatment for invasive bladder cancer - Abstract
Tuesday, 02 February 2010
Departamento de Urología, Institut Montsouris, Université Paris Descartes, París, Francia.
read more

Validation of the AJCC TNM Substaging of pT2 bladder cancer: Deep muscle invasion is associated with significantly worse outcome - Abstract
Tuesday, 02 February 2010
University Hospital Munich Grosshadern, Ludwig Maximilians University, Munich, Germany.
read more

Galectin expression in urological cancer : Diagnostic, prognostic and therapeutic potential - Abstract
Tuesday, 02 February 2010
Klinik für Urologie und urologische Onkologie, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland.
read more

Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder - Abstract
Monday, 01 February 2010
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
read more

A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Clinical and pathological results - Abstract
Monday, 01 February 2010
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
read more

The role of pathology review of transurethral bladder tumor resection specimens in the modern era - Abstract
Monday, 01 February 2010
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
read more

Urothelial carcinoma of the sarcomatoid variant in a young patient with spina bifida - Abstract
Monday, 01 February 2010
Department of Urology, "Asklipieion" General Hospital, Athens, Greece.
read more

Androgen receptor is a potential therapeutic target for bladder cancer - Abstract
Friday, 29 January 2010
Department of Urology, First People's Hospital Affiliated to Shanghai, Jiao Tong University, Shanghai, China.
read more

Lifetime exposure to arsenic in drinking water and bladder cancer: A population-based case-control study in Michigan, USA - Abstract
Friday, 29 January 2010
Graduate Program in Public Health, Department of Preventive Medicine, Stony Brook University Medical Center, HSC L3, Rm 071, Stony Brook, NY, 11794-8338, USA.
read more

Detection of bladder cancer in voided urine samples - Abstract
Friday, 29 January 2010
Service d'Urologie, CHU de Liège, Belgique.
read more

Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria - Abstract
Thursday, 28 January 2010
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas.
read more

Clinical epidemiology of nonurothelial bladder cancer: Analysis of The Netherlands Cancer Registry - Abstract
Thursday, 28 January 2010
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
read more

Oncological outcomes after radical cystectomy for bladder cancer: Open versus minimally invasive approaches - Abstract
Thursday, 28 January 2010
Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
read more

Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma - Abstract
Wednesday, 27 January 2010
Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
read more

Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients - Abstract
Wednesday, 27 January 2010
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (Forlì-Cesena)- Italy.
read more

Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer - Abstract
Wednesday, 27 January 2010
Health Services Research Unit, Institute of Applied Health Sciences, University of Aberdeen, UK.
read more

Robot-assisted radical cystectomy: Recent advances and review of the literature - Abstract
Tuesday, 26 January 2010
Department of Urology (MEW), Loyola University Medical Center, Maywood, Illinois, USA.
read more

Investigational therapies for non-muscle invasive bladder cancer - Abstract
Tuesday, 26 January 2010
University of Pittsburgh Medical Center, Department of Urology, Kaufmann Building, 3471 5th Avenue, Pittsburgh, PA 15213, USA.
read more

Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses - Abstract
Tuesday, 26 January 2010
Cochrane Unit, Research Department, Velindre NHS Trust, Whitchurch, Cardiff, Wales CF14 2TL, UK.
read more

The impact of multiple malignancies on patients with bladder carcinoma: A population-based study using the SEER database - Abstract
Monday, 25 January 2010
Department of Urology, New York Presbyterian Hospital, Weill Medical College of Cornell University, 525 East 68th Street, Starr 900, New York, NY 10021, USA.
read more

Developing selection criteria for prostate-sparing cystectomy: A review of cystoprostatectomy specimens - Abstract
Monday, 25 January 2010
Department of Urology, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston-Salem, North Carolina.
read more

A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer - Abstract
Monday, 25 January 2010
Institute of Urology, University of Palermo, Palermo, Italy.
read more

Galectin expression in urological cancer: Diagnostic, prognostic and therapeutic potential - Abstract
Friday, 22 January 2010
Klinik für Urologie und urologische Onkologie, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland.
read more

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial - Abstract
Friday, 22 January 2010
University of Münster, Münster, Germany.
read more

Survival of patients with bladder cancer from a UK hospital: a 10-year follow-up study - Abstract
Friday, 22 January 2010
Department of Surgery, Division of Surgery and Cancer, Imperial College London, London, UK.
read more

p38 Mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity - Abstract
Friday, 22 January 2010
Signal Transduction and Molecular Urology Laboratory, Program in Urosciences, Division of Urology, Department of Surgery, School of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, USA.
read more

Surveillance strategies after definitive therapy of invasive bladder cancer - Abstract
Thursday, 21 January 2010
Division of Urology, University of Ottawa, Ottawa, ON.
read more

Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer - Abstract
Thursday, 21 January 2010
Division of Urology, McGill University Health Center, Montreal, Canada.
read more

Molecular screening for bladder cancer: progress and potential - Abstract
Thursday, 21 January 2010
Department of Pathology, Keck School of Medicine, University of Southern California, Health Sciences Campus, 2011 Zonal Avenue, HMR 308, Los Angeles, CA 90033, USA.
read more

The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis - Abstract
Thursday, 21 January 2010
Department of Mathematics and Statistics, University of Prince Edward Island, Charlottetown, Canada.
read more

Personalized medicine in advanced urothelial cancer: When to treat, how to treat and who to treat - Abstract
Wednesday, 20 January 2010
Department of Urology; Department of Molecular Physiology; Paul Mellon Urologic Cancer Institute, University of Virginia, Charlottesville, VA.
read more

The star chart to Ta bladder cancer: An unsophisticated analysis of two-dimensional gel electrophoresis proteome maps - Abstract
Wednesday, 20 January 2010
Oslo Urological University Clinic, Oslo University Hospital, Aker, Oslo, Norway.
read more

Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma - Abstract
Wednesday, 20 January 2010
Department of Pathology, Harper University Hospital, Wayne State University School of Medicine, and Karmanos Cancer Institute, Detroit, MI 48201, USA.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts